Virtus ETF Advisers’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-65,813
| Closed | -$397K | – | 501 |
|
|
2019
Q4 | $397K | Sell |
65,813
-24,741
| -27% | -$149K | 0.06% | 258 |
|
|
2019
Q3 | $326K | Sell |
90,554
-5,044
| -5% | -$18.2K | 0.07% | 192 |
|
|
2019
Q2 | $256K | Buy |
95,598
+8,694
| +10% | +$23.3K | 0.05% | 269 |
|
|
2019
Q1 | $257K | Sell |
86,904
-8,913
| -9% | -$26.4K | 0.55% | 76 |
|
|
2018
Q4 | $152K | Sell |
95,817
-62,460
| -39% | -$99.1K | 0.03% | 181 |
|
|
2018
Q3 | $582K | Sell |
158,277
-113,149
| -42% | -$416K | 0.06% | 103 |
|
|
2018
Q2 | $768K | Buy |
271,426
+9,142
| +3% | +$25.9K | 0.68% | 53 |
|
|
2018
Q1 | $973K | Buy |
262,284
+141,020
| +116% | +$523K | 0.84% | 46 |
|
|
2017
Q4 | $349K | Buy |
121,264
+43,831
| +57% | +$126K | 0.44% | 91 |
|
|
2017
Q3 | $348K | Buy |
77,433
+7,083
| +10% | +$31.8K | 0.05% | 123 |
|
|
2017
Q2 | $323K | Buy |
70,350
+900
| +1% | +$4.13K | 0.05% | 102 |
|
|
2017
Q1 | $292K | Buy |
69,450
+6,658
| +11% | +$28K | 0.05% | 140 |
|
|
2016
Q4 | $259K | Buy |
62,792
+35,877
| +133% | +$148K | 0.08% | 131 |
|
|
2016
Q3 | $218K | Hold |
26,915
| – | – | 0.11% | 132 |
|
|
2016
Q2 | $210K | Buy |
26,915
+1,204
| +5% | +$9.39K | 0.16% | 133 |
|
|
2016
Q1 | $198K | Buy |
+25,711
| New | +$198K | 0.27% | 85 |
|